Vice President of ASH Will Focus on Gene Therapies, ASH's Global Impact
The field of hematology is experiencing significant advancements as promising new therapies for malignancies and GVHD continue to emerge.
United States Los Angeles Stanford University Robert Negrin Roberts Negrin European Hematology Association
Source: onclive.com